Analutos was formed in September 2010 when it was decided that all commercial undertakings of ESPA Research should be removed allowing it to concentrate wholly on research. Profits from Analutos go towards supporting ESPA Research and its work into improving the quality of life for people with Autism and related conditions.
The three directors of Analutos consist of two directors from ESPA Research (Dr. Paul Whiteley and Kevin Carr, with Kevin Carr taking up the role of managing director) and Paul Shattock OBE, President of The World Autism Organisation.
Analutos uses the most up to date equipment and techniques in all of its analysis. Most of our analysis is done by Mass Spectrometry; our equipment includes a Q-ToF (Quadrapole Time of Flight) and two triple quad mass spectrometers.